Lady with history of depression came to the OPD and was prescribed on Imipramine One wk later bystanders complained that she is having hallucination and excessive talking what will you advice on follow up
**Core Concept**
Imipramine, a tricyclic antidepressant (TCA), can cause Central Nervous System (CNS) toxicity, particularly at higher doses, leading to adverse effects such as hallucinations, excessive talking, and other neurological symptoms. This is due to its anticholinergic and antihistaminic properties, as well as its ability to block norepinephrine and serotonin reuptake.
**Why the Correct Answer is Right**
The patient's symptoms suggest TCA toxicity, which can occur due to overdose, rapid dose escalation, or individual sensitivity. The anticholinergic effects of imipramine can lead to hallucinations, agitation, and other CNS disturbances, while its antihistaminic effects can cause sedation and excessive talking. It is essential to monitor the patient's vital signs, perform a thorough physical examination, and consider laboratory tests to rule out other potential causes of her symptoms.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not relevant to the clinical scenario, as it does not address the patient's symptoms or the potential causes of TCA toxicity.
**Option B:** The patient's symptoms do not suggest a need for increased medication, as this could exacerbate the CNS toxicity. Instead, the focus should be on reducing the dose or switching to a different medication.
**Option C:** While it is essential to monitor the patient's vital signs and perform a thorough physical examination, this option does not address the specific concern of TCA toxicity.
**Clinical Pearl / High-Yield Fact**
TCAs can cause CNS toxicity at higher doses, and it is crucial to monitor patients closely for signs of anticholinergic and antihistaminic effects, such as hallucinations, excessive talking, and sedation.
**Correct Answer:** A. Monitor vital signs, physical examination, and consider laboratory tests.